Vanaja Konduri

Company: Diakonos Oncology

Job title: VP Research & Development

Seminars:

Vaccination by Homologous Antigenic Loading as Adjuvant Therapy for Glioblastoma: Phase I Clinical Trial Analysis 4:15 pm

Developing a novel autologous dendritic cell therapy vaccine (DOC1021) as adjuvant therapy for GBM DOC1021 is safe, can be effectively integrated within existing standards of care and appears efficacious in a challenging patient population Strong correlations between vaccine genetic signature and peripheral immune responses were observed Analyzing the survival data Median survival of this 15/16…Read more

day: Conference Day 1